Fosfomycin tromethamine: Single-dose treatment of acute cystitis

International Journal of Fertility and Women's Medicine

Volumn 44, Issue 2, 1999, Pages 104-109

  Stein, Gary E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Acute cystitis; Fosfomycin tromethamine

Indexed keywords

COTRIMOXAZOLE; FOSFOMYCIN TROMETAMOL; NITROFURANTOIN; NORFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; CONFERENCE PAPER; CYSTITIS; DRUG POTENCY; DRUG SAFETY; DRUG URINE LEVEL; HUMAN; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CYSTITIS; DRUG RESISTANCE; FEMALE; FOSFOMYCIN; HUMANS; INFANT; MALE; PREGNANCY; TROMETHAMINE;

EID: 0032914008     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Ronald A, Nicolle LE, Harding G: Single dose treatment failure in women with acute cystittis. Infection 20(Suppl 4):S276-279, 1992.
2. Hatton J, Hughes M, Raymond CH: Management of bacterial urinary tract infections in adults. Ann Pharmacother 28:1264-1272, 1994.
3. Naber KG: Uncomplicated urinary tract infections - is single-dose therapy effective? Int J Antimicrob Agents 4(Suppl 2)839-45, 1994.
4. Stamm WE: Controversies in single dose therapy of acute uncomplicated urinary tract infections in women. Infection 20(Suppl 4):S272-275, 1992.
5. Reeves DS: Clinical efficacy and safety of fosfomycin trometamol in the prevention and treatment of urinary tract infections. Rev Contemp Pharmacother 6:71-83, 1995.
6. Kahan FM, Kahan JS, Cassidy JP, et al: The mechanisms of action of fosfomycin. Ann NY Acad Sci 235:364-386, 1974.
7. Carlone NA, Borsotto M, Cuffini AM, et al: Effects of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents. Eur Urol 13(Suppll):86-91, 1987.
8. Barry AL, Brown SD: Antibacterial spectrum of fosfomycin trometamol. J Antimicrob Chemother 35: 228-230, 1995.
9. Barry AL, Fuchs PC: In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrob Agents Chemother 35:1235-1238, 1991.
10. Pfaller MA, Barry AL, Fuchs PC: Evaluation of disk susceptibility testing of fosfomycin tromethamine. Diagn Microbiol Infect Dis 17:67-70, 1993.
11. Reeves DS, Holt HA, Bywater MJ: In vitro study of fosfomycin trometamol, in Neu HC, William JD (eds): New Trends in Urinary Tract Infections. Basel, Karger, pp 224-231, 1988.
12. Cornaglia G, Pompei R, Foddis G, et al: Antibacterial activity of fosfomycin trometamol in an in vitro model of the urinary bladder, in Neu HC, Williams JD (eds): New Trends in Urinary Tract Infections. Basel, Karger, pp 255-260, 1988.
13. Kadner RJ, Winkler HH: Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol 113:895-900, 1973.
14. Area P, Hardisson C, Suarez JE: Purification of a glutathione S-transferase that mediates resistance in bacteria. Antimicrob Agents Chemother 34:844-848, 1990.
15. Lerner SA, Price S, Kulkarni S: Microbiological studies of fosfomycin trometamol against urinary isolate in vitro, in Neu HC, Williams JD (eds): New Trends in Urinary Tract Infections. Basel, Switzerland, Karger, pp 121-129, 1988.
16. Greenwood D: Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis. Infection 14:186-189, 1986.
17. Greenwood D, Edwards R, Brown J, et al: The comparative activity of fosfomycin trometamol against organisms isolated from infected urines. Infection 20(Suppl 4):302-304, 1992.
18. Bergan T: Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity. Infection 18(Suppl 2):65-69, 1990.
19. Reeves DS: Fosfomycin trometamol. J Antimicrobiol Chemother 34:853-858, 1994.
20. Bergan T: Pharmacokinetics of fosfomycin. Rev Contemp Pharmacother 6:55-62, 1995.
21. Ferreres L, Paz M, Martin G, et al: New studies on placental transfer of fosfomycin. Chemotherapy 23(Suppl 1):175-179, 1977. 7
22. Fillastre JP, Leroy A, Humbert G, et al: Comparative pharmacokinetics of fosfomycin trometamol versus calcium fosfomycin in elderly subjects and uraemic patients, in: Neu HC, Williams JD (eds); New Trends in Urinary Tract Infections. Basel, Switzerland, pp 143-156, 198 8.
23. Kirby WMM: Pharmacokinetics of fosfomycin. Chemotherapy 23(Suppl 1);141-151; 1977.
24. Ragni N, Pivetta C, Paccagnella F, et al: Urinary tract infections in pregnancy, in: Neu HC, Williams D (eds): New Trends in Urinary Tract Infections. Basel, Switzerland, Karger, pp 197-206, 1988.
25. Careddu P, Borzani M, Varotto F, et al: Trometamol salt of fosfomycin (Monuril). Eur Urol 13(Suppl 1):114-118, 1987.
26. Borgia M, Longo A, Lodola E: Relative bioavailability of fosfomycin and of trometamol after administration of single-dose by oral route of fosfomycin trometamol in fasting conditions and after a meal. Int J Clin Pharmacol Ther Toxicol 27:411-417, 1989.
27. Package insert - Monurol (fosfomycin tromethamine). St. Louis, Forest Laboratories, Inc., 1997.
28. Bergan T, Mastropaolo G, DiMario F, et al: Pharmacokinetics of fosfomycin and influence of cimetidine and metoclopramide on the bioavailability of fosfomycin trometamol, in Neu HC, Williams JD (eds): New Trends in Urinary Tract Infections. Basel, Switzerland, Karger, pp 157-166, 1988.
29. Boerema JBJ, Williams FTC: Fosfomycin trometamol in single dose versus norfloxacin for seven days in treatment of uncomplicated urinary infections in general practice. Infection 18(Suppl 2):S80-88, 1990.
30. Van Pienbroek E, Hermans J, Kaptein AA, et al: Fosfomycin trometamol in a single dose versus seven days of nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharm World Sci 61:257-262, 1993.
31. Davis HR, O'Dowd TC, Holmes W, et al: A compara tive double-blind randomized study of single-dose fosfomycin trometamol with trimethaprim in the treatment of uncomplicated urinary tract infections in general practice. Chemotherapy 36(Suppl 1):34-36, 1990.
32. Selvaggi FP, Ditonno P, Taficante A, et al: Fosfomycin trometamol versus norfloxacin in single-dose for adult female uncomplicated UTIs. Chemotherapy 36(Suppl 1):31-33, 1990.
33. Peratoner L, Corrias A, Tumbarello R, et al: Fosfomycin trometamol versus netilmicin in pediatric urinary tract infection, in Neu HC, Williams JD (eds): New Trends in Urinary Tract Infections. Basel, Karger, pp 171-177, 1988.
34. Thoumsin H, Aghayan M, Lambotte R: Single-dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. Infection 18(Suppl 2):94-97, 1990.
35. Ferraro G, Ambrosi G, Bucci L, et al: Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections in the elderly. Chemotherapy 36(Suppl 1):46-9, 1990.
36. Palmieri G, Palmieri R, Ambrosi G, et al: A new single-dose antibiotic in urinary tract infection in elderly patinets, in Neu HC, Williams JD (Eds): New Trends in Urinary Tract Infections. Basel, Karger, pp 322-324, 1988.
37. MacGowan AP, Bailey RA, Egner W, et al: An open study of the efficacy and safety of single-dose fosfomycin trometamol treatment of hospitalized patients with urinary tract infection (pilot study). Infection 18(Suppl 2):107-108, 1990.
38. Rolandi E, Indiereri F: Fosfomycin trometamol singledose therapy in lower urinary tract infections of elderly women, Neu HC, Williams JD (eds): New Trends in Urinary Tract Infections. Basel, Karger, pp 319-321, 1988.
39. Naber KG: Fosfomycin trometamol in treatment of uncomplicated lower urinary tract infections in adult women - an overview. Infection 20(Suppl 4):S310-311, 1992.
40. Naber KG, Johnson FN: The safety and tolerability of fosfomycin trometamol. Rev Contemp Pharmcother 6:63-70, 1995.
41. Reeves DS: Treatment of bacteriuria in pregnancy with single-dose fosfomycin trometamol: a review. Infection 20(Suppl 4):S313-316, 1992.